Ishares Msci Brazil ETF vs Heron Therapeutics Inc — how do they compare? Ishares Msci Brazil ETF trades at $33.93, while Heron Therapeutics Inc trades at $0.33 (market cap $61.47M). The key difference: Ishares Msci Brazil ETF is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| EWZ | HRTX | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $41.75 | $1.49 |
52-Week Low | $27.36 | $0.32 |
Market Cap | — | $61.47M |
Enterprise Value | — | $168.21M |
Signals from Pluang's Aura AI — not financial advice
EWZ, the iShares MSCI Brazil ETF, trades at $33.94, down 3.55% today, with a bearish technical signal driven by moving averages. The ETF faces headwinds from US tariffs on Brazilian goods and mixed sentiment, though oscillators suggest potential near-term support. A dividend of $0.33 is scheduled for June 2026, while institutional investors like Empowered Funds LLC have recently increased positions, indicating some confidence in Brazilian equity value.
The outlook for EWZ hinges on Brazil's economic policies and commodity markets, offering exposure to emerging market growth but with volatility risks from trade tensions and currency fluctuations. Investors should weigh the ETF's high expense ratio against alternatives like FLBR, which offers lower costs and higher dividends, as noted in recent analyst comparisons.
HRTX trades at $0.3152, down 4.54% today, amid bearish technical signals and mixed earnings. The stock shows a high gross margin of 70.07% but negative net income margins, with Q2 2026 missing revenue and EPS estimates. Recent news highlights patent litigation developments and quarterly results falling short of expectations, contributing to investor caution.
The outlook remains challenged by persistent losses and operational cash burn, though analyst consensus is strongly bullish with 94.74% buy ratings. Key risks include execution on product sales, competitive pressures, and reliance on financing activities to sustain operations amid negative profitability.
Trailing returns across standard periods
Latest headlines on both assets
EWZ is a country-specific ETF that tracks the Brazilian equity market. It provides exposure to large and mid-sized companies in Brazil, with a heavy focus on financials and materials, including major names like Nu Holdings, Vale, and Itaú Unibanco.
Read more on EWZ →Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →